• UCB acquires gene therapy specialist Handl Therapeutics pharmatimes
    November 12, 2020
    UCB has announced its acquisition of Belgium-based gene therapy company Handl Therapeutics, in a move that will bolster its pipeline programmes, capabilities and platforms in the gene therapy space.
PharmaSources Customer Service